These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32331932)

  • 41. In vitro reactivation of latent HIV-1 by cytostatic bis(thiosemicarbazonate) gold(III) complexes.
    Fonteh P; Meyer D
    BMC Infect Dis; 2014 Dec; 14():680. PubMed ID: 25495419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents.
    Petravic J; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP
    J Virol; 2017 May; 91(9):. PubMed ID: 28202759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance.
    Liu J; Kelly J; Yu W; Clausen D; Yu Y; Kim H; Duffy JL; Chung CC; Myers RW; Carroll S; Klein DJ; Fells J; Holloway MK; Wu J; Wu G; Howell BJ; Barnard RJO; Kozlowski JA
    ACS Med Chem Lett; 2020 Jul; 11(7):1476-1483. PubMed ID: 32676157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitors.
    Thaler F; Varasi M; Abate A; Carenzi G; Colombo A; Bigogno C; Boggio R; Zuffo RD; Rapetti D; Resconi A; Regalia N; Vultaggio S; Dondio G; Gagliardi S; Minucci S; Mercurio C
    Eur J Med Chem; 2013 Jun; 64():273-84. PubMed ID: 23644210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and biological evaluation of optically pure functionalized spiro[5,5]undecane-1,5,9-triones as HIV-1 inhibitors.
    Ramachary DB; Reddy YV; Banerjee A; Banerjee S
    Org Biomol Chem; 2011 Nov; 9(21):7282-6. PubMed ID: 21915419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation.
    Albert BJ; Niu A; Ramani R; Marshall GR; Wender PA; Williams RM; Ratner L; Barnes AB; Kyei GB
    Sci Rep; 2017 Aug; 7(1):7456. PubMed ID: 28785069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV "shock and kill" therapy: In need of revision.
    Abner E; Jordan A
    Antiviral Res; 2019 Jun; 166():19-34. PubMed ID: 30914265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
    Banga R; Procopio FA; Cavassini M; Perreau M
    J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.
    Kim Y; Anderson JL; Lewin SR
    Cell Host Microbe; 2018 Jan; 23(1):14-26. PubMed ID: 29324227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.
    Macedo AB; Novis CL; De Assis CM; Sorensen ES; Moszczynski P; Huang SH; Ren Y; Spivak AM; Jones RB; Planelles V; Bosque A
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutics for HIV-1 reactivation from latency.
    Sgarbanti M; Battistini A
    Curr Opin Virol; 2013 Aug; 3(4):394-401. PubMed ID: 23810462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b.
    Liang T; Zhang X; Lai F; Lin J; Zhou C; Xu X; Tan X; Liu S; Li L
    Biochem Pharmacol; 2019 Jun; 164():237-251. PubMed ID: 30991051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Latency reversal and viral clearance to cure HIV-1.
    Margolis DM; Garcia JV; Hazuda DJ; Haynes BF
    Science; 2016 Jul; 353(6297):aaf6517. PubMed ID: 27463679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heme arginate potentiates latent HIV-1 reactivation while inhibiting the acute infection.
    Shankaran P; Vlkova L; Liskova J; Melkova Z
    Antiviral Res; 2011 Dec; 92(3):434-46. PubMed ID: 22001321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone deactylase inhibitor SAHA induces a synergistic HIV-1 reactivation by 12-O-tetradecanoylphorbol-13-acetate in latently infected cells.
    Park SY; Kim KC; Hong KJ; Kim SS; Choi BS
    Intervirology; 2013; 56(4):242-8. PubMed ID: 23735807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
    Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
    J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents.
    Khatun S; Amin SA; Choudhury D; Chowdhury B; Jha T; Gayen S
    Expert Opin Drug Discov; 2024 Mar; 19(3):353-368. PubMed ID: 38258439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural product-derived compounds in HIV suppression, remission, and eradication strategies.
    Andersen RJ; Ntie-Kang F; Tietjen I
    Antiviral Res; 2018 Oct; 158():63-77. PubMed ID: 30063970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.
    Boehm D; Ott M
    AIDS Res Hum Retroviruses; 2017 Nov; 33(S1):S8-S22. PubMed ID: 29140109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.